Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Home Diagnostics, Inc. - CITP
03 Febrero 2010 - 10:45AM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Home Diagnostics, Inc. (“Home Diagnostics” or the “Company”)
(NasdaqGS: HDIX) for possible breaches of fiduciary duty and other
violations of state law in connection with their attempt to sell
the Company to Nipro Corp. Under the terms of the transaction, Home
Diagnostics shareholders will receive $11.50 per share in cash for
each share of Home Diagnostics they own for a total transaction
value is approximately $215 million.
The investigation concerns whether the Home Diagnostics Board of
Directors breached their fiduciary duties to Home Diagnostics
stockholders by failing to adequately shop the Company before
entering into this transaction and whether Nipro Corp. is
underpaying for Home Diagnostics shares, thus unlawfully harming
Home Diagnostics stockholders.
If you are a current holder of Home Diagnostics and would like
additional information, please contact us at the number listed
below or visit http://www.zlk.com/hdix1.html.
Levi & Korsinsky has expertise in prosecuting investor
securities litigation and extensive experience in actions involving
financial fraud and represents investors throughout the nation,
concentrating its practice in securities and shareholder
litigation.
Home Diagnostics (MM) (NASDAQ:HDIX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Home Diagnostics (MM) (NASDAQ:HDIX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Home Diagnostics (MM) (NASDAQ): 0 recent articles
Más de Levi & Korsinsky Artículos de Noticias